Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review

被引:18
|
作者
Mauriello, Claudio [1 ]
Napolitano, Salvatore [3 ]
Gambardella, Claudio [1 ]
Candela, Giancarlo [1 ]
De Vita, Ferdinando [2 ]
Orditura, Michele [2 ]
Sciascia, Valerio [1 ]
Tartaglia, Ernesto [1 ]
Lanza, Michele [1 ]
Santini, Luigi [1 ]
Conzo, Giovanni [1 ]
机构
[1] Univ Naples 2, Sch Med, Dept Anaesthesiol Surg & Emergency Sci, Unit Gen & Oncol Surg, I-80131 Naples, Italy
[2] Univ Naples 2, Sch Med, Dept Clin & Expt Med, Div Oncol, I-80131 Naples, Italy
[3] Minist Def, Italian Air Force Med Corps, Rome, Italy
关键词
Pancreatic neuroendocrine tumors; Conservative management; Parenchyma-sparing resections; Intraoperative ultrasonography; Thompson procedure; MULTIPLE-ENDOCRINE-NEOPLASIA; HIPPEL-LINDAU-DISEASE; SURGICAL-MANAGEMENT; INJECTION TEST; SURGERY; TYPE-1; GUIDELINES; CANCER;
D O I
10.1016/j.ijsu.2015.04.089
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Pancreatic neuroendocrine tumors (pNETs) are uncommon entities. pNETs are often small, slow growing, clinically silent neoplasms. However, they have an almost unpredictable biological behaviour with a not negligible malignant potential. Surgery still represents the treatment of choice, but the high morbidity associated to the enucleation or the formal pancreatectomy should be considered in the decision of the proper treatment. Management of these neoplasms is still debated, and indications for a conservative observational approach and for parenchyma sparing resections are not yet standardized. Method: We review the state of art on the indications for the conservative management of pNETs. Searches on MEDLINE database were performed to identify articles reporting prognostic systems, biochemical screening, observational management, medical treatment and surgical strategies for pNETs. Discussion: Currently, an accurate 'wait-and-see' policy is recommended by the European Neuroendocrine Tumor Society (ENETS) only for non-functioning pNETs (NF-pNETs) <2 cm. A biochemical screening, based on sampling of serum levels of pancreatic polypeptide (PP) and chromogranin A, can address to early conservative surgery for MEN-1 associated NF-pNETs <2 cm to prevent their malignant transformation. The subtotal (80%) distal pancreatectomy first proposed by Thompson, often with the enucleation of possible pancreatic head tumors, still represents a good compromise between oncological radicality and prevention of pancreatic endocrine/exocrine insufficiency caused by standard radical resections for the treatment of inherited syndromes associated with NF-pNETs >2 cm and symptomatic F-pNETs of any size. Conclusion: More studies are needed to further clarify and predict the biologic behaviour of pNETs and increase the indications for conservative observational management and parenchyma sparing pancreas resections. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S10 / S14
页数:5
相关论文
共 50 条
  • [11] Laparoscopic parenchyma-sparing resections for solid pseudopapillary tumors located in the head of pancreas
    Zou, Zhengdong
    Feng, Lu
    Peng, Bing
    Liu, Jianhua
    Cai, Yunqiang
    BMC SURGERY, 2023, 23 (01)
  • [12] Laparoscopic parenchyma-sparing resections for solid pseudopapillary tumors located in the head of pancreas
    Zhengdong Zou
    Lu Feng
    Bing Peng
    Jianhua Liu
    Yunqiang Cai
    BMC Surgery, 23
  • [13] Parenchyma-sparing resection for pancreatic neoplasms
    Pedrazzoli, Sergio
    Canton, Alen Silvio
    Sperti, Cosimo
    Pasquali, Claudio
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2010, 17 (02) : 203 - 203
  • [14] One Hundred Thirty Resections for Pancreatic Neuroendocrine Tumor: Evaluating the Impact of Minimally Invasive and Parenchyma-Sparing Techniques Discussion
    Vollmer, Charles M.
    Allendorf, John
    Pitt, Henry
    JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (10) : 1545 - 1546
  • [15] Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors &lt;3 cm in a Large Multicenter Cohort
    Bolm, Louisa
    Nebbia, Martina
    Wei, Alice C.
    Zureikat, Amer H.
    Fernandez-del Castillo, Carlos
    Zheng, Jian
    Pulvirenti, Alessandra
    Javed, Ammar A.
    Sekigami, Yurie
    Petruch, Natalie
    Qadan, Motaz
    Lillemoe, Keith D.
    He, Jin
    Ferrone, Cristina R.
    ANNALS OF SURGERY, 2022, 276 (03) : 522 - 531
  • [16] Parenchyma-Sparing Bronchial Sleeve Resections in Trauma, Benign and Malign Diseases
    Boeluekbas, S.
    Schirren, J.
    THORACIC AND CARDIOVASCULAR SURGEON, 2010, 58 (01): : 32 - 37
  • [17] Limited Parenchyma-Sparing Pancreatic Head Resection for Benign Neuroendocrine Tumors and Cystic Neoplasms—the Use of Duodenum-Preserving Head Resection
    Daniel Gavrila
    Monica Lacatus
    Hans G. Beger
    Stefan Tudor
    Catalin Vasilescu
    Indian Journal of Surgery, 2020, 82 : 371 - 376
  • [18] Parenchyma-Sparing Central Hepatectomy Versus Extended Resections for Liver Tumors: a Value-Based Comparative Analysis
    Rothermel, Luke D.
    Powers, Benjamin D.
    Byrne, Margaret M.
    McCarthy, Kevin
    Denbo, Jason W.
    Ehab, Jasmina
    Fleming, Jason B.
    Anaya, Daniel A.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (07) : 1406 - 1415
  • [19] Parenchyma-Sparing Central Hepatectomy Versus Extended Resections for Liver Tumors: a Value-Based Comparative Analysis
    Luke D. Rothermel
    Benjamin D. Powers
    Margaret M. Byrne
    Kevin McCarthy
    Jason W. Denbo
    Jasmina Ehab
    Jason B. Fleming
    Daniel A. Anaya
    Journal of Gastrointestinal Surgery, 2022, 26 : 1406 - 1415
  • [20] Laparoscopic Multiple Parenchyma-sparing Concomitant Liver Resections for Colorectal Liver Metastases
    Kazaryan, Airazat M.
    Aghayan, David L.
    Barkhatov, Leonid I.
    Fretland, Asmund A.
    Edwin, Bjorn
    SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 2019, 29 (03): : 187 - 193